I-SPY2 Endocrine Optimization Pilot (EOP): Neoadjuvant Amcenestrant +/- Abemaciclib +/- Letrozole in Molecularly Selected Patients (pts) with HR+ HER2- Stage 2/3 Breast Cancer (BC).
Journal of Clinical Oncology(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined